Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2002, p. 2791-2796, Vol. 46, No. 9
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.9.2791-2796.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre Cédex, France
Received 5 November 2001/ Returned for modification 9 February 2002/ Accepted 21 May 2002
Chryseobacterium gleum (previously included in the Flavobacterium IIb species) is a gram-negative aerobe that is a source of nosocomial infections. An Ambler class B ß-lactamase gene was cloned and expressed in Escherichia coli from reference strain C. gleum CIP 103039 that had reduced susceptibility to expanded-spectrum cephalosporins and carbapenems. The purified ß-lactamase, CGB-1, with a pI value of 8.6 and a determined relative molecular mass of ca. 26 kDa, hydrolyzed penicillins; narrow- and expanded-spectrum cephalosporins; and carbapenems. CGB-1 was a novel member of the molecular subclass B1 of metallo-enzymes. It had 83 and 42% amino acid identity with IND-1 from Chryseobacterium indologenes and BlaB from C. meningosepticum, respectively. Thus, in addition to the previously characterized clavulanic acid-inhibited extended-spectrum ß-lactamase CGA-1 of Ambler class A, C. gleum produces a very likely chromosome-borne class B ß-lactamase.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»